Table 4. Characteristics of the cohort population overall and by grouped titers of anti-leptospira antibody by MAT.
| Characteristic | Anti-leptospira antibody MAT titers | |||||
|---|---|---|---|---|---|---|
| Total (n = 88) | MAT negative (n = 12) | MAT = 100–200 (n = 41) | MAT≥400 (n = 35) | |||
| Age | 55.8 ± 15.0 | 61.7 ± 14.0 | 56.5 ± 14.1 | 53.1 ± 16.1 | ||
| Male (%) | 38.2 | 25.0 | 31.7 | 50.0 | ||
| BMI | 23.8 ± 3.3 | 22.3 ± 2.8 | 24.4 ± 3.5 | 23.6 ± 3.1 | ||
| Waist circumference (cm) | 81.6 ± 11.1 | 78.1 ± 9.6 | 82.7 ± 11.5 | 81.5 ± 11.2 | ||
| Hip circumference (cm) | 94.8 ± 7.7 | 92.7 ± 7.0 | 96.6 ± 8.1 | 93.5 ± 7.5 | ||
| Medical History | ||||||
| Diabetes Mellitus (%) | 20.6 | 14.3 | 19.6 | 24.3 | ||
| Hypertension (%) | 26.3 | 14.3 | 36.4 | 18.9 | ||
| Microalbuminuria (%) | 14.4 | 14.3 | 15.2 | 13.5 | ||
| Laboratory data | ||||||
| Creatinine (mg/dl) | 0.7 ± 0.2 | 0.7 ± 0.2 | 0.8 ± 0.2 | 0.8 ± 0.2 | ||
| eGFR (ml/min/1.73 m 2 ) 1 | 105.9 ± 17.4 | 104.6 ± 20.0 | 105.0 ± 16.3 | 107.4 ± 18.0 | ||
| Hematocrit (%), mean± SD | 41.7 ± 3.9 | 41.0 ± 4.1 | 41.2 ± 4.5 | 42.7 ± 2.7 | ||
| RBC (10 6 /±l) | 4.7 ± 0.6 | 4.4 ± 0.5 | 4.7 ± 0.5 | 4.8 ± 0.6 | ||
| Hemoglobin (g/dl) | 14.0 ± 1.6 | 13.8 ± 1.6 | 13.7 ± 1.9 | 14.3 ± 1.1 | ||
| BUN (mg/dl) | 13.6 ± 4.9 | 14.0 ± 2.9 | 14.1 ± 6.3 | 12.8 ± 3.1 | ||
| AST (IU/L) | 27.8 ± 10.9 | 26.5 ± 4.7 | 28.4 ± 13.2 | 27.4 ± 9.5 | ||
| ALT (IU/L) | 25.4 ± 12.8 | 23.6 ± 7.9 | 25.4 ± 14.4 | 26.4 ± 11.9 | ||
| HDL cholesterol (mg/dl) | 51.2 ± 13.3 | 49.9 ± 8.9 | 51.0 ± 12.8 | 51.8 ± 15.1 | ||
| LDL cholesterol (mg/dl) | 123.2 ± 28.8 | 130.3 ± 33.6 | 119.4 ± 25.9 | 125.3 ± 30.5 | ||
| Total Cholesterol (mg/dl) | 200.9 ± 32.2 | 208.0 ± 32.5 | 196.6 ± 33.2 | 203.4 ± 31.2 | ||
| Triglyceride (mg/dl) | 120.9 ± 107.6 | 92.6 ± 61.1 | 114.9 ± 60.9 | 137.4 ± 152.0 | ||
| Uric Acid (mg/dl) | 6.3 ± 1.6 | 5.5 ± 0.8 | 6.6 ± 1.8 | 6.2 ± 1.5 | ||
Values expressed with a plus/minus sign are the mean ± SD; AST indicates aspartate aminotransferase; ALT indicates alanine aminotransferase;
1The eGFR, estimated GFR, was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation